OBI Pharma’s Board of Directors approves the announcement of the Company’s 2017 individual and consolidated financial statements

1. Date of occurrence of the event: 2018/03/09 2. Company name: OBI Pharma, Inc 3. Relationship to the Company (please enter “head office” or “subsidiaries”):Parent 4. Reciprocal shareholding ratios: N/A 5. Cause of occurrence: The Company’s 2017 individual and consolidated financial statements were approved by the board of directors. Essential financial items are presented below. […]